Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individualsMarco Bongiovanni, Antonella d’Arminio Monforte, Elisabetta Chiesa et al.|International Journal of Antimicrobial Agents|2005Cited by 33
Virological Success of Lopinavir/Ritonavir Salvage Regimen is Affected by an Increasing Number of Lopinavir/Ritonavir-Related MutationsMarco Bongiovanni, Antonella d’Arminio Monforte, Teresa Bini et al.|Antiviral Therapy|2003Cited by 25
Predictive Factors of Hyperlipidemia in HIV-Infected Subjects Receiving Lopinavir/RitonavirMarco Bongiovanni, Antonella d’Arminio Monforte, Fulvio Adorni et al.|AIDS Research and Human Retroviruses|2006Cited by 17